Transgene Biotek has informed that at the meeting of the board of directors of the company held on 23rd January 2021 has approved the Unaudited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the quarter ended on 31st December 2020.
The above information is a part of company’s filings submitted to BSE.